| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceptable Safety of Bevacizumab Therapy in Patients with Brain Metastases as a Result of Non—Small-Cell Lung Cancer
|
Akerley, Wallace
|
|
2008
|
9 |
Supplement 3 |
p. 306-
1 p.
|
artikel
|
| 2 |
A Phase II Study of Erlotinib as a First-Line Therapy for Patients with Non—Small-Cell Lung Cancer with Favorable Clinical Predictors
|
Lee, Dae Ho
|
|
2008
|
9 |
Supplement 3 |
p. 297-
1 p.
|
artikel
|
| 3 |
Assessment of Guilt and Shame in Patients with Non–Small-Cell Lung Cancer Compared with Patients with Breast and Prostate Cancer
|
LoConte, Noelle K.
|
|
2008
|
9 |
Supplement 3 |
p. 171-178
8 p.
|
artikel
|
| 4 |
Chemotherapy for Brain Metastases in Small-Cell Lung Cancer
|
Chen, Gigi
|
|
2008
|
9 |
Supplement 3 |
p. 35-38
4 p.
|
artikel
|
| 5 |
Conformal Radiation Therapy as Definitive Treatment of Stage I Non—Small-Cell Lung Cancer: University of California San Diego Experience
|
Sandhu, Ajay
|
|
2008
|
9 |
Supplement 3 |
p. 299-
1 p.
|
artikel
|
| 6 |
Current State of Vaccine Therapies in Non–Small-Cell Lung Cancer
|
Romero, Pedro
|
|
2008
|
9 |
Supplement 3 |
p. S28-S36
9 p.
|
artikel
|
| 7 |
Early Clinical Trial Experience with Vaccine Therapies in Non–Small-Cell Lung Cancer
|
Ho, Cheryl
|
|
2008
|
9 |
Supplement 3 |
p. S20-S27
8 p.
|
artikel
|
| 8 |
Emerging Safety Data for Bevacizumab in Advanced Non–Small-Cell Lung Cancer
|
Hirsh, Vera
|
|
2008
|
9 |
Supplement 3 |
p. S62-S70
9 p.
|
artikel
|
| 9 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as a First-Line Therapy for Never-Smokers with Adenocarcinoma of the Lung and Asymptomatic Synchronous Brain Metastasis
|
Lee, Dae Ho
|
|
2008
|
9 |
Supplement 3 |
p. 296-
1 p.
|
artikel
|
| 10 |
Esophageal and Laryngeal Cancer Incidentally Found on [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography During the Staging Workup for Lung Cancer
|
Jeon, Se Yong
|
|
2008
|
9 |
Supplement 3 |
p. 230-231
2 p.
|
artikel
|
| 11 |
First Report of Worldwide Use of Internet-Based Survivorship Care Plans by Lung Cancer Survivors
|
Metz, J.M.
|
|
2008
|
9 |
Supplement 3 |
p. 298-
1 p.
|
artikel
|
| 12 |
Fractionated Stereotactic Body Radiation Therapy in the Treatment of Primary, Recurrent, and Metastatic Lung Tumors: The Role of Positron Emission Tomography/Computed Tomography–Based Treatment Planning
|
Coon, Devin
|
|
2008
|
9 |
Supplement 3 |
p. 217-221
5 p.
|
artikel
|
| 13 |
Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology; Chicago, IL; May 30-June 3, 2008
|
Ranganathan, Aarati
|
|
2008
|
9 |
Supplement 3 |
p. 196-200
5 p.
|
artikel
|
| 14 |
Metronomic Chemotherapy in Patients with Advanced Non—Small-Cell Lung Cancer Associated with Long-Term Survival
|
Chen, Nick
|
|
2008
|
9 |
Supplement 3 |
p. 290-
1 p.
|
artikel
|
| 15 |
New Data Integrating Multitargeted Antifolates into Treatment of First-line and Relapsed Non–Small-Cell Lung Cancer
|
Scagliotti, Giorgio Vittorio
|
|
2008
|
9 |
Supplement 3 |
p. S122-S128
7 p.
|
artikel
|
| 16 |
Ongoing Trials with Bevacizumab and Other Antiangiogenic Agents in Lung Cancer
|
Dowlati, Afshin
|
|
2008
|
9 |
Supplement 3 |
p. S71-S75
5 p.
|
artikel
|
| 17 |
Patterns of Radiation Therapy Practice in Nonmetastatic Non—Small-Cell Lung Cancer: Results of Web-Based Patterns of Care Study in Korea
|
Wu, Hong-Gyun
|
|
2008
|
9 |
Supplement 3 |
p. 304-
1 p.
|
artikel
|
| 18 |
Phase I Study of Flavopiridol in Combination with Paclitaxel and Carboplatin in Patients with Non–Small-Cell Lung Cancer
|
George, Saby
|
|
2008
|
9 |
Supplement 3 |
p. 160-165
6 p.
|
artikel
|
| 19 |
Population Characteristics and Prognostic Factors in Metastatic Non–Small-Cell Lung Cancer: A Fox Chase Cancer Center Retrospective
|
Paralkar, Vikram R.
|
|
2008
|
9 |
Supplement 3 |
p. 116-121
6 p.
|
artikel
|
| 20 |
Preliminary Treatment Patterns and Safety Outcomes for Non—Small-Cell Lung Cancer from ARIES, a Bevacizumab Treatment Observational Cohort Study
|
Spigel, David
|
|
2008
|
9 |
Supplement 3 |
p. 302-
1 p.
|
artikel
|
| 21 |
Relationship Between Symptom Change, Objective Tumor Measurements, and Performance Status During Chemotherapy for Advanced Lung Cancer
|
Cella, David
|
|
2008
|
9 |
Supplement 3 |
p. 51-58
8 p.
|
artikel
|
| 22 |
Restrictive Eligibility Limits Access to Newer Therapies in Non–Small-Cell Lung Cancer: The Implications of Eastern Cooperative Oncology Group 4599
|
Somer, Robert A.
|
|
2008
|
9 |
Supplement 3 |
p. 102-105
4 p.
|
artikel
|
| 23 |
Single-Agent Epidermal Growth Factor Receptor Inhibitor Gefitinib for the Treatment of Patients with Advanced Non—Small-Cell Lung Cancer and Poor Performance Status
|
Karim, Nagla Abdel
|
|
2008
|
9 |
Supplement 3 |
p. 293-294
2 p.
|
artikel
|
| 24 |
Sunitinib plus Erlotinib for the Treatment of Metastatic Non—Small-Cell Lung Cancer: A Novel VEGFR—EGFR Co-Inhibition Treatment Strategy
|
Scagliotti, Giorgio V.
|
|
2008
|
9 |
Supplement 3 |
p. 300-
1 p.
|
artikel
|
| 25 |
Targeting Dishevelled, a mediator of Wnt/β-Catenin Signaling Pathway, in Human Non—Small-Cell Lung Cancer
|
Chen, Zhao
|
|
2008
|
9 |
Supplement 3 |
p. 305-
1 p.
|
artikel
|
| 26 |
The Clinical Development of Vandetanib: Updates on Ongoing Phase III Clinical Trials in Advanced Non—Small-Cell Lung Cancer
|
Heymach, John
|
|
2008
|
9 |
Supplement 3 |
p. 292-
1 p.
|
artikel
|
| 27 |
The Future of Cancer Vaccines for Non–Small-Cell Lung Cancer: Ongoing Trials
|
Choudhury, Aniruddha
|
|
2008
|
9 |
Supplement 3 |
p. S37-S44
8 p.
|
artikel
|
| 28 |
The Role of Targeting Mammalian Target of Rapamycin in Lung Cancer
|
Pal, Sumanta Kumar
|
|
2008
|
9 |
Supplement 3 |
p. 340-345
6 p.
|
artikel
|
| 29 |
Tracheoesophageal Fistula Development and Concurrent Chemoradiation and Bevacizumab in Non—Small-Cell Lung Cancer
|
Spigel, David R.
|
|
2008
|
9 |
Supplement 3 |
p. 303-
1 p.
|
artikel
|
Tijdschrift beschrijving